Dr. Adam Kuehn

Dr. Adam Kuehn, MD has a wealth of experience in the medical field. Dr. Adam started their career at CBLPath in 2006 as the Medical Director of Uropathology. Dr. Adam then joined UCA in 2006 and served as the Medical Director until 2014. In 2011, Dr. Kuehn became the Medical Director at Premier Urology Associates, LLC d.b.a. AdvanceMed Research, where they worked until 2019.

In 2015, Dr. Kuehn worked as a Consultant at Axella BioVentures. Dr. Adam then transitioned to Celularity Inc. in 2018, where they held multiple roles. Dr. Adam served as the Medical Laboratory Director, overseeing a cord blood bank and tissue-based products, until 2020. Dr. Adam also served as the Director of Medical Affairs for Functional Regeneration until 2022, providing medical insights and support to cross-functional teams. Currently, at Celularity Inc., Dr. Kuehn serves as the Medical Director Clinical Development Solid Tumors, leading two clinical studies focused on natural killer cells derived cellular therapies in solid tumor clinical research. Dr. Adam provides clinical development oversight to all clinical operations.

Dr. Adam Kuehn, MD completed a fellowship in Uropathology at Emory University School of Medicine from 2005 to 2006. Dr. Adam also obtained a Master's Degree in Biotechnology Enterprise and Entrepreneurship from The Johns Hopkins University starting in 2014. Additional education history includes attending Rutgers medica and St. Barnabas Medical Center, but no specific degrees or fields of study are provided for these institutions.